What's in AryoGen Pharmed Co.'s pipeline?

AryoGen Pharmed Co. has 3 drugs in our index: 1 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with AryoGen Pharmed Co.'s portfolio?

Top competitors by shared drug class: American Scitech International, Baxalta now part of Shire, Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd., Cinnagen, Fondazione Italiana Linfomi - ETS.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/aryogen-pharmed-co.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

AryoGen Pharmed Co. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

AryoGen Pharmed Co. pipeline: 1 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Novoseven	Novoseven	marketed			Other
Bevacizumab + FOLFIRI-3	Bevacizumab + FOLFIRI-3	phase 3	Monoclonal antibody + chemotherapy combination	VEGF (bevacizumab); Thymidylate synthase and topoisomerase I (FOLFIRI-3)	Oncology
Eptacog alfa, biosimilar	Eptacog alfa, biosimilar	phase 3	Recombinant coagulation factor	Tissue factor (TF); Factor X	Hematology

Therapeutic area mix

Hematology · 1
Oncology · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

American Scitech International · 1 shared drug class
Baxalta now part of Shire · 1 shared drug class
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · 1 shared drug class
Cinnagen · 1 shared drug class
Fondazione Italiana Linfomi - ETS · 1 shared drug class
Fujian Medical University · 1 shared drug class
Nicoletta C Machin · 1 shared drug class
Nordic Lymphoma Group · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for AryoGen Pharmed Co.:

Cite this brief

Drug Landscape (2026). AryoGen Pharmed Co. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/aryogen-pharmed-co. Accessed 2026-05-16.